Pakistan has taken a major step toward advancing cancer research and treatment through strengthened collaboration with China at the 2025 China Conference on Holistic Integrative Oncology (CCHIO), held in Kunming. The global event brought together more than 100,000 participants, including 6,000 international experts, showcasing innovation and partnership in the fight against cancer.
Dr. Muhammad Shahbaz, President of the China-Pakistan Medical Association (CPMA), represented Pakistan and described the conference as a turning point for global oncology cooperation. A notable highlight for Pakistan was the launch of the Urdu-translated version of the China Anti-Cancer Association (CACA) Guidelines for Cancer Treatment. These guidelines, now available in 16 languages, aim to make advanced cancer care knowledge accessible to clinicians worldwide.
Dr. Shahbaz said the Urdu translation will help Pakistani doctors adopt standardized and evidence-based treatment protocols, improving patient outcomes nationwide. The conference also explored collaboration in genomics, early detection, and advanced therapeutics tailored to Pakistan’s cancer profile.
To enhance knowledge exchange, Dr. Shahbaz proposed a Sister University Partnership between Kunming Medical University and Nishtar Medical University in Multan. The initiative will promote research cooperation, student exchange programs, and joint training for medical professionals.
The discussions also included technology transfer for advanced radiotherapy equipment such as the KylinRay MELAC Linear Accelerator, which would bring cost-effective, cutting-edge treatment options to Pakistani hospitals. Meetings were also held with representatives of the Belt and Road Healthcare Center, highlighting opportunities for Pakistan to become a regional hub for affordable, high-quality cancer care through the “Health Silk Road.”
Dr. Shahbaz emphasized that the CCHIO 2025 embodies the spirit of international partnership in combating cancer. He said Pakistan’s participation reinforces its commitment to collaborative healthcare progress, echoing China’s vision of shared innovation and a healthier future.
Related stories:
